Tag Archives: HIMX

Northland Securities Sticks to Their Hold Rating for Himax Technologies (HIMX)

Northland Securities analyst Tim Savageaux maintained a Hold rating on Himax Technologies (HIMX – Research Report) today and set a price target of $3.50. The company’s shares closed last Monday at $3.27. According to TipRanks.com, Savageaux is a 4-star analyst

Northland Securities Maintains a Hold Rating on Himax Technologies (HIMX)

Northland Securities analyst Tim Savageaux maintained a Hold rating on Himax Technologies (HIMX – Research Report) yesterday and set a price target of $2.25. The company’s shares closed last Monday at $2.54. According to TipRanks.com, Savageaux is a 4-star analyst

Northland Securities Maintains Their Hold Rating on Himax Technologies (HIMX)

Northland Securities analyst Tim Savageaux maintained a Hold rating on Himax Technologies (HIMX – Research Report) today and set a price target of $2.50. The company’s shares closed yesterday at $2.71, close to its 52-week low of $2.62. Savageaux noted:

Himax Technologies (HIMX) Receives a Hold from Northland Securities

Northland Securities analyst Tim Savageaux maintained a Hold rating on Himax Technologies (HIMX – Research Report) today and set a price target of $3. The company’s shares closed yesterday at $3.51, close to its 52-week low of $3.03. According to

Friday’s Midday Stock Update: Anthera Pharmaceuticals (ANTH), ImmunoCellular Therapeutics (IMUC), Northwest Biotherapeutics (NWBO), Terra Tech Corp (TRTC), Himax Technologies (HIMX)

So far Friday, November 16, NASDAQ is down -0.18% and the S&P is up 0.79%. Let’s take a look at this morning’s most active stocks and their recent analyst insights; Anthera Pharmaceuticals (ANTH – Research Report), ImmunoCellular Therapeutics (IMUC –

Friday’s Highlights at Noon: Anthera Pharmaceuticals (ANTH), ImmunoCellular Therapeutics (IMUC), Northwest Biotherapeutics (NWBO), Himax Technologies (HIMX), Terra Tech Corp (TRTC)

So far Friday, November 16, NASDAQ is down -0.18% and the S&P is up 0.66%. Here are this morning’s most active stocks: Anthera Pharmaceuticals (ANTH – Research Report), ImmunoCellular Therapeutics (IMUC – Research Report), Northwest Biotherapeutics (NWBO – Research Report),